http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4038193-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b909ce71fa3f2750cc818e4671e294 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8283 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-82 |
| filingDate | 2020-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f857a49394b6e0f1832d965004588d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2707c90ce04f89faf4ad60c58901955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4885c9095b0e0d995594bbbe6f14b6db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_438eea9ce94c7272ce6ef9ba48c3bfad |
| publicationDate | 2022-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-4038193-A1 |
| titleOfInvention | Begomovirus resistance related genes |
| abstract | The present invention relates to a modified PriL gene, which encodes a modified protein comprising one or more modifications in the wild type protein sequence of SEQ ID No. 1 or SEQ ID No. 3 or in a protein sequence having at least 60% sequence identity to SEQ ID No. 1 or SEQ ID No. 3. Alternatively, the wild type of the modified PriL gene encodes a protein according to SEQ ID No. 1, SEQ ID No. 3, SEQ ID No. 7, SEQ ID No. 11, SEQ ID No. 13, SEQ ID No. 15, SEQ ID No. 17, SEQ ID No. 19, SEQ ID No. 21, SEQ ID No. 23, SEQ ID No. 25, SEQ ID No. 27, SEQ ID No. 29, or SEQ ID No. 31. The modification in the wild type protein sequence is an amino acid substitution, in particular a phenylalanine (F) to cysteine (C) substitution at a position corresponding to position 147 according to SEQ ID No. 5, and/or glycine (G) to aspartic acid (D) substitution at a position corresponding to position 162 according to SEQ ID No. 5, and/or a glutamine (Q) to histidine (H) substitution at a position corresponding to position 163 according to SEQ ID No. 5, and/or wherein the modified gene encodes a modified protein that comprises a tyrosine (Y) to histidine (H) substitution at a position corresponding to position 4 according to SEQ ID No. 9, and/or a proline (P) to glutamine (Q) substitution at a position corresponding to position 166 according to SEQ ID No. 9, and/or an isoleucine (I) to threonine (T) substitution at a position corresponding to position 200 according to SEQ ID No. 9. |
| priorityDate | 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 359.